In testing robotic systems, developers can fail and learn, as long as they control risk, explains Bullen Ultrasonics' ...
GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...
OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...
Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...
In this conference report from ABRF 2026, the authors reflect on the meeting's insights into core facility research and ...
Advances in artificial intelligence promise to help chemical engineers discover complex new materials. These materials could ...
What is next for batteries? Through prismatic, chemistry-agnostic cells, Priyadarshi Panda of International Battery Company ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
Airtable and Notion continue to be major players in core business solutions, demonstrating solid growth. Talkdesk, Benchling, ...
Zhang, J., Zhai, L., Sun, J.D., Yang, C.C., Zhang, Y., Sun, Y.N., Wu, Z.J. and Luo, H.J. (2026) Effect of Glycine Betaine on ...
Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business is launching Signals BioDesignTM, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results